Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3127c0ebee3f865b211b019fac84286 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-1032 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-1031 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B40-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B25-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10 |
filingDate |
2016-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61b945064befd27e42e1e7e1aa067aa1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa7b7bcf87144648b8c42afc7f0d3c47 |
publicationDate |
2018-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2018148791-A1 |
titleOfInvention |
Systems and methods for providing personalized radiation therapy |
abstract |
An example method of treating a subject having a tumor is described herein. The method can include determining a radiosensitivity index of the tumor, deriving a subject-specific variable based on the radiosensitivity index, and obtaining a genomic adjusted radiation dose effect value for the tumor. The radiosensitivity index can be assigned from expression levels of signature genes of a cell of the tumor. Additionally, the genomic adjusted radiation dose effect value can be predictive of tumor recurrence in the subject after treatment. The method can also include determining a radiation dose based on the subject-specific variable and the genomic adjusted radiation dose effect value. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020082071-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021051052-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10556125-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11439843-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018296856-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11547871-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11426603-B2 |
priorityDate |
2015-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |